Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fitch

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Pharmacogenetics and Genomics|October 19, 2012
Identification of drug targets by chemogenomic and metabolomic profiling in yeastManhong Wu, Ming Zheng, Weiruo Zhang, et al.
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Life Sciences|January 1, 1997
Monoclonal antibodies as surrogate receptors in a high throughput screen for compounds that enhance insulin sensitivityS W Bright, G Gold, S W Sage, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2018
PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injuryKaren De Ceunynck, Christian G Peters, Abhishek Jain, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Phosphodiesterase type 1 regulates adenosine 2A receptor-associated cAMP signaling at the plasma membrane to increase myocardial contractilityMichael L Fitch, Maria Alexandria Martins Goncalves, Mary Tang, et al.
Blood|May 13, 2015
Platelet geometry sensing spatially regulates α-granule secretion to enable matrix self-depositionYumiko Sakurai, Jennifer L Fitch-Tewfik, Yongzhi Qiu, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 26, 2006
Three-dimensional reconstruction of fracture callus morphogenesisLouis C Gerstenfeld, Yaser M Alkhiary, Elizabeth A Krall, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Pharmacogenetics and Genomics|October 19, 2012
Identification of drug targets by chemogenomic and metabolomic profiling in yeastManhong Wu, Ming Zheng, Weiruo Zhang, et al.
JAMA|September 16, 1992
Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) GroupH Buchwald, J P Matts, L L Fitch, et al.
The New England Journal of Medicine|October 4, 1990
Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)H Buchwald, R L Varco, J P Matts, et al.
Controlled Clinical Trials|April 11, 1991
Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH GroupJ P Matts, H Buchwald, L L Fitch, et al.
Life Sciences|January 1, 1997
Monoclonal antibodies as surrogate receptors in a high throughput screen for compounds that enhance insulin sensitivityS W Bright, G Gold, S W Sage, et al.
Journal of Clinical Epidemiology|March 1, 1995
Subgroup analyses of the major clinical endpoints in the Program on the Surgical Control of the Hyperlipidemias (POSCH): overall mortality, atherosclerotic coronary heart disease (ACHD) mortality, and ACHD mortality or myocardial infarctionJ P Matts, H Buchwald, L L Fitch, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2018
PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injuryKaren De Ceunynck, Christian G Peters, Abhishek Jain, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Phosphodiesterase type 1 regulates adenosine 2A receptor-associated cAMP signaling at the plasma membrane to increase myocardial contractilityMichael L Fitch, Maria Alexandria Martins Goncalves, Mary Tang, et al.
Blood|May 13, 2015
Platelet geometry sensing spatially regulates α-granule secretion to enable matrix self-depositionYumiko Sakurai, Jennifer L Fitch-Tewfik, Yongzhi Qiu, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 26, 2006
Three-dimensional reconstruction of fracture callus morphogenesisLouis C Gerstenfeld, Yaser M Alkhiary, Elizabeth A Krall, et al.
Pageof 14